Shingles (Herpes Zoster) Vaccination Information for Healthcare Providers
ShareCompartir
One of the Recommended Vaccines by Disease
Shingles vaccine has been licensed since 2006. Zostavax® is the only shingles vaccine currently approved for use in the United States. This vaccine reduces the risk of developing shingles by 51% and post-herpetic neuralgia (PHN) by 67%. It is administered subcutaneously as a single dose, and can be given in a doctor’s office or pharmacy. CDC recommends shingles vaccine for people age 60 years and older. Even people who have had shingles can receive the vaccine to help prevent future occurrences of the disease.
-
Shingles/Herpes Zoster Vaccine Recommendations
ACIP vaccine recommendations for people 60 years old and older, vaccination of people 50-59 years old, and the contraindications and precautions for zoster vaccination -
About the Vaccine
Information about shingles vaccine composition, dosage, and administration as well as vaccine effectiveness and duration of protection -
Storage and Handling
General information about vaccine storage and handling as well as shingles-specific storage practices and guidelines -
Administering the Vaccine
Administrating Zostavax with other vaccines and possible vaccine administration errors -
References and Resources
Materials for patients and resources for providers
- Page last reviewed: November 22, 2016
- Page last updated: November 22, 2016
- Content source: